Cost-Effectiveness of SGLT2is vs DPP4is in Patients With Type 2 Diabetes With and Without Established Cardiovascular Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cost-effectiveness of SGLT2is versus DPP4is among type 2 diabetes patients with and without established cardiovascular disease: A model-based simulation analysis using 10-year real-world data and targeted literature review
Diabetes Obes Metab 2022 Apr 04;[EPub Ahead of Print], ZY Peng, CT Yang, HT Ou, S KuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.